by Bob Wold | Nov 29, 2022 | News
Featuring Clusterbusters and Board Member Joe McKay.
by Bob Wold | Nov 23, 2022 | News
Featuring Clusterbusters and Board Member Ainslie Course. Free subscription required to access.
by Bob Wold | Nov 23, 2022 | News
The first results of a small randomized controlled study of psilocybin for cluster headache have been published in the medical journal Headache. The study showed a good effect size for psilocybin treatment and the safety of the substance was demonstrated. Participants...
by Bob Wold | Apr 18, 2022 | News
One understudied condition for which small doses of psychedelic substances such as psilocybin may be beneficial is cluster headache. As founder and executive director of the advocacy group Clusterbusters, I have seen firsthand, as a patient and an activist, that,...
by Bob Wold | Nov 28, 2021 | News
Cluster headache epidemiology including pediatric onset, sex, and ICHD criteria: Results from the International Cluster Headache Questionnaire Abstract Objective To validate the diagnoses and to investigate epidemiological data from an international, non-clinic-based,...
